Suchergebnisse - "Jarrett, James"

PubPharm (6)

1

Correction to : Comparative efficacy of advanced treatments in biologic-naïve or biologic-experienced patients with ulcerative colitis: a systematic review and network meta-analysis

enthalten in: International journal of clinical pharmacy | 2023

von Lu, X. | Jarrett, J. | Sadler, S. | +3

ErratumFor: Int J Clin Pharm. 2023 Apr;45(2):330-341. - PMID 36484968

2

Remdesivir-related cost-effectiveness and cost and resource use evidence in COVID-19 : a systematic review

enthalten in: Infection | 2023

von Murton, M. | Drane, E. | Jarrett, J. | +2

3

Comparative efficacy of advanced treatments in biologic-naïve or biologic-experienced patients with ulcerative colitis : a systematic review and network meta-analysis

enthalten in: International journal of clinical pharmacy | 2023

von Lu, X. | Jarrett, J. | Sadler, S. | +3

ErratumIn: Int J Clin Pharm. 2023 Mar 19;:. - PMID 36934390

4

Correction to: Comparative efficacy of advanced treatments in biologic-naïve or biologic-experienced patients with ulcerative colitis: a systematic review and network meta-analysis

enthalten in: Pharmacy world & science | 2023

von Lu, X. | Jarrett, J. | Sadler, S. | +3

5

Comparative efficacy of advanced treatments in biologic-naïve or biologic-experienced patients with ulcerative colitis: a systematic review and network meta-analysis

enthalten in: Pharmacy world & science | 2022

von Lu, X. | Jarrett, J. | Sadler, S. | +3

6

Remdesivir-related cost-effectiveness and cost and resource use evidence in COVID-19: a systematic review

enthalten in: Infection | 2022

von Murton, M. | Drane, E. | Jarrett, J. | +2

1
[1]